Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Reilley MJ"'
Autor:
Coveler AL; Fred Hutchinson Cancer Center, Seattle, Washington., Reilley MJ; University of Virginia Comprehensive Cancer Center, Charlottesville, Virginia., Zalupski M; University of Michigan Health System, Ann Arbor, Michigan., Macarulla T; Vall d'Hebrón Institute of Oncology (VHIO), Vall d'Hebrón University Hospital, Barcelona, Spain., Fountzilas C; Roswell Park Comprehensive Cancer Center, Buffalo, New York., Ponz-Sarvisé M; Cancer Center Clinica Universidad de Navarra, Pamplona, Spain., Nagrial A; Blacktown Hospital, Sydney, Australia., Uboha NV; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin., Frentzas S; Monash Medical Centre, Clayton, Australia., Overman M; The University of Texas MD Anderson Cancer Center, Houston, Texas., Noonan A; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Messersmith WA; University of Colorado Cancer Center, Aurora, Colorado., Pavlakis N; Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, Australia., Mettu NB; Duke University Medical Center, Durham, North Carolina., Bisha I; AstraZeneca, Munich, Germany., Wang Y; AstraZeneca, Waltham, Massachusetts., Smith P; On behalf of AstraZeneca, Cambridge, United Kingdom., Murtomaki E; AstraZeneca, Cambridge, United Kingdom., Bielska AA; AstraZeneca, Waltham, Massachusetts., Bragulat V; AstraZeneca, Cambridge, United Kingdom., Cooper ZA; AstraZeneca, Gaithersburg, Maryland., Kumar R; AstraZeneca, Gaithersburg, Maryland., Spigel DR; Sarah Cannon Research Institute, Nashville, Tennessee.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Oct 15; Vol. 30 (20), pp. 4609-4617.
Autor:
Segal NH; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA., Tie J; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Kopetz S; MD Anderson Cancer Center, Houston, TX, USA., Ducreux M; Paris-Saclay University, Gustave Roussy Cancer Center, Villejuif, France., Chen E; Princess Margaret Cancer Centre, Toronto, ON, Canada., Dienstmann R; Vall d'Hebron University Hospital and Institute of Oncology (VHIO), IOB-Quiron, Barcelona, Spain.; University of Vic-Central, University of Catalonia (UVic-UCC), Vic, Spain.; Oncoclínicas Precision Medicine, Oncoclínicas, São Paulo, Brazil., Hollebecque A; Gustave Roussy Cancer Center, Villejuif, France., Reilley MJ; University of Virginia Comprehensive Cancer Center, Charlottesville, VA, USA., Elez E; Vall d'Hebron University Hospital and Institute of Oncology (VHIO), IOB-Quiron, Barcelona, Spain., Cosaert J; AstraZeneca, Cambridge, UK., Cain J; AstraZeneca, Gaithersburg, MD, USA., Soo-Hoo Y; AstraZeneca, Gaithersburg, MD, USA., Hewson N; AstraZeneca, Cambridge, UK., Cooper ZA; AstraZeneca, Gaithersburg, MD, USA., Kumar R; AstraZeneca, Gaithersburg, MD, USA., Tabernero J; Vall d'Hebron University Hospital and Institute of Oncology (VHIO), IOB-Quiron, Barcelona, Spain. jtabernero@vhio.net.; University of Vic-Central, University of Catalonia (UVic-UCC), Vic, Spain. jtabernero@vhio.net.
Publikováno v:
British journal of cancer [Br J Cancer] 2024 Oct; Vol. 131 (6), pp. 1005-1013. Date of Electronic Publication: 2024 Jul 25.
Autor:
Ali LR; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts., Lenehan PJ; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts., Cardot-Ruffino V; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts., Dias Costa A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Katz MHG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Bauer TW; Department of Surgery, University of Virginia Health System, Charlottesville, Virginia., Nowak JA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Abrams TA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Patel A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Clancy TE; Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Wang J; Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Mancias JD; Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Reilley MJ; Division of Hematology and Oncology, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia., Stucky CH; Mayo Clinic College of Medicine and Science, Mayo Clinic, Phoenix, Arizona., Bekaii-Saab TS; Mayo Clinic College of Medicine and Science, Mayo Clinic, Phoenix, Arizona., Elias R; Hartford Healthcare Cancer Institute, Hartford, Connecticut., Merchant N; Department of Surgery, University of Miami, Miami, Florida., Slingluff CL Jr; Department of Surgery, University of Virginia Health System, Charlottesville, Virginia., Rahma OE; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Dougan SK; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Feb 01; Vol. 30 (3), pp. 542-553.
Autor:
Katz MHG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA mhgkatz@mdanderson.org., Petroni GR; Division of Translational Research and Applied Statistics, Department of Public Health Sciences, University of Virginia Health System, Charlottesville, Virginia, USA., Bauer T; Department of Surgery, University of Virginia Health System, Charlottesville, Virginia, USA., Reilley MJ; Division of Hematology and Oncology, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA., Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Stucky CC; Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA., Bekaii-Saab TS; Division of Hematology and Medical Oncology, Department of Internal Medicine, Mayo Clin, Phoenix, Arizona, USA., Elias R; Hartford HealthCare Cancer Institute, Plainville, Connecticut, USA., Merchant N; Department of Surgery, University of Miami, Coral Gables, Florida, USA., Dias Costa A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA., Lenehan P; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Immunology, Harvard Medical School, Boston, Massachusetts, USA., Cardot-Ruffino V; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Immunology, Harvard Medical School, Boston, Massachusetts, USA., Rodig S; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Immunology, Harvard Medical School, Boston, Massachusetts, USA., Pfaff K; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Dougan SK; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Immunology, Harvard Medical School, Boston, Massachusetts, USA., Nowak JA; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Immunology, Harvard Medical School, Boston, Massachusetts, USA., Varadhachary GR; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Slingluff CL; Department of Surgery, University of Virginia Health System, Charlottesville, Virginia, USA., Rahma O; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Dec 01; Vol. 11 (12). Date of Electronic Publication: 2023 Dec 01.
Autor:
Lucchesi N; Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA., Ally JM; Division of Hematology Oncology, University of Virginia Health System, Charlottesville, Virginia, USA., Reilley MJ; Department of Medicine, University of Virginia, Charlottesville, Virginia, USA mr7db@virginia.edu.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Sep; Vol. 11 (9).
Autor:
Daniel KE; Center for Behavioral Health and Technology, University of Virginia, PO Box 801075, Charlottesville, VA, 22908, USA., Glazer JV; Center for Behavioral Health and Technology, University of Virginia, PO Box 801075, Charlottesville, VA, 22908, USA., Le T; Emily Couric Comprehensive Cancer Center, University of Virginia, Charlottesville, VA, USA., Reilley MJ; Emily Couric Comprehensive Cancer Center, University of Virginia, Charlottesville, VA, USA., Jameson MJ; Avera Medical Group ENT-Head & Neck Surgery, Sioux Falls, SD, USA., Chow PI; Center for Behavioral Health and Technology, University of Virginia, PO Box 801075, Charlottesville, VA, 22908, USA., Ritterband LM; Center for Behavioral Health and Technology, University of Virginia, PO Box 801075, Charlottesville, VA, 22908, USA., Shaffer KM; Center for Behavioral Health and Technology, University of Virginia, PO Box 801075, Charlottesville, VA, 22908, USA. kshaffer@virginia.edu.
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2023 Aug 30; Vol. 31 (9), pp. 542. Date of Electronic Publication: 2023 Aug 30.
Autor:
Chow PI; Department of Psychiatry and Neurobehavioral Sciences, Center for Behavioral Health and Technology, University of Virginia, USA.; Cancer Center, University of Virginia, USA., Roller DG; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, USA., Boukhechba M; Department of Engineering Systems and Environment, University of Virginia, USA.; Janssen Pharmaceutical Companies of Johnson & Johnson, USA., Shaffer KM; Department of Psychiatry and Neurobehavioral Sciences, Center for Behavioral Health and Technology, University of Virginia, USA., Ritterband LM; Department of Psychiatry and Neurobehavioral Sciences, Center for Behavioral Health and Technology, University of Virginia, USA.; Cancer Center, University of Virginia, USA., Reilley MJ; Department of Medicine, University of Virginia, USA., Le TM; Department of Medicine, University of Virginia, USA., Kunk PR; Department of Medicine, University of Virginia, USA., Bauer TW; Department of Surgery, University of Virginia, USA.; Cancer Center, University of Virginia, USA., Gioeli DG; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, USA.; Cancer Center, University of Virginia, USA.
Publikováno v:
Internet interventions [Internet Interv] 2023 Jul 08; Vol. 34, pp. 100644. Date of Electronic Publication: 2023 Jul 08 (Print Publication: 2023).
Autor:
Devall M; Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia, USA.; Department of Family Medicine, University of Virginia, Charlottesville, Virginia, USA., Ali MW; Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia, USA., Eaton S; Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia, USA.; Department of Family Medicine, University of Virginia, Charlottesville, Virginia, USA., Weisenberger DJ; Department of Biochemistry and Molecular Medicine, University of Southern California, Los Angeles, California, USA., Reilley MJ; University of Virginia Comprehensive Cancer Center, University of Virginia, Charlottesville, Virginia, USA., Powell SM; Digestive Health Center, University of Virginia, Charlottesville, Virginia, USA., Li L; Department of Family Medicine, University of Virginia, Charlottesville, Virginia, USA.; University of Virginia Comprehensive Cancer Center, University of Virginia, Charlottesville, Virginia, USA., Casey G; Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia, USA.; Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, USA.
Publikováno v:
Cancer medicine [Cancer Med] 2023 Jun; Vol. 12 (12), pp. 13551-13572. Date of Electronic Publication: 2023 May 10.
Autor:
Sorah JD; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Moore DT; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Reilley MJ; Division of Hematology/Oncology, Department of Medicine, University of Virginia, Charlottesville, VA, USA., Salem ME; Levine Cancer Institute, Charlotte, NC, USA., Triglianos T; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Sanoff HK; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., McRee AJ; The Janssen Pharmaceutical Companies of Johnson & Johnson, Raritan, NJ, USA., Lee MS; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
The oncologist [Oncologist] 2022 Dec 09; Vol. 27 (12), pp. 1006-e930.
Feasibility of ecological momentary assessment to study depressive symptoms among cancer caregivers.
Autor:
Shaffer KM; Department of Psychiatry and Neurobehavioral Sciences, Center for Behavioral Health and Technology, University of Virginia, Charlottesville, Virginia, USA.; Emily Couric Clinical Cancer Center, University of Virginia, Charlottesville, Virginia, USA., Chow PI; Department of Psychiatry and Neurobehavioral Sciences, Center for Behavioral Health and Technology, University of Virginia, Charlottesville, Virginia, USA.; Emily Couric Clinical Cancer Center, University of Virginia, Charlottesville, Virginia, USA., Glazer JV; Department of Psychiatry and Neurobehavioral Sciences, Center for Behavioral Health and Technology, University of Virginia, Charlottesville, Virginia, USA., Le T; Emily Couric Clinical Cancer Center, University of Virginia, Charlottesville, Virginia, USA.; Department of Medicine, Division of Hematology/Oncology, University of Virginia, Charlottesville, Virginia, USA., Reilley MJ; Emily Couric Clinical Cancer Center, University of Virginia, Charlottesville, Virginia, USA.; Department of Medicine, Division of Hematology/Oncology, University of Virginia, Charlottesville, Virginia, USA., Jameson MJ; Department of Medicine, Division of Hematology/Oncology, University of Virginia, Charlottesville, Virginia, USA.; Department of Otolaryngology, Division of Head and Neck Surgery, University of Virginia, Charlottesville, Virginia, USA., Ritterband LM; Department of Psychiatry and Neurobehavioral Sciences, Center for Behavioral Health and Technology, University of Virginia, Charlottesville, Virginia, USA.; Emily Couric Clinical Cancer Center, University of Virginia, Charlottesville, Virginia, USA.
Publikováno v:
Psycho-oncology [Psychooncology] 2021 May; Vol. 30 (5), pp. 756-764. Date of Electronic Publication: 2021 Jan 28.